Global Head Lice Infestation Drug Market Growth 2019-2024

Published On: Mar 2019

Format: PDF

Publisher: LP infomation

Pages: 165

Report ID: 237329

Head lice are tiny wingless insects that do not fly or jump, their primary means of movement is crawling. The main way lice are spread is head to head contact. Lice are human parasites that feed on the blood of the infested person.
The Global Main Head Lice Infestation Drug Manufacturers are Bayer, Omega Pharma, Thornton and Ross, Prestige Brands and other manufacturers. Bayer is one of the largest manufacturers in the global Head Lice Infestation Drug market with 11.35% market share in 2015, followed by Omega Pharma with 7.98% market share.
The Head Lice Infestation Drug sales regions are mainly North America and Europe. North America is the largest region to consumption Head Lice Infestation Drug, whose consumption occupied about 31.40% in 2015, followed by Europe with 29.01% consumption share.
After a long investigation and research, we think people are very concerned about the Head Lice Infestation Drug content in the daily commodities. We recommend that some manufacturers would add Head Lice Infestation Drug to satisfy the market demanding for all household members and other close to head lice contacts should be checked.

According to this study, over the next five years the Head Lice Infestation Drug market will register a 4.3% CAGR in terms of revenue, the global market size will reach US$ 440 million by 2024, from US$ 340 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Head Lice Infestation Drug business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Head Lice Infestation Drug market by product type, application, key manufacturers and key regions and countries.

This study considers the Head Lice Infestation Drug value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Lotion
Creams
Shampoo
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Children
Adult

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bayer
Omega Pharma
Thornton and Ross
Prestige Brands
Perrigo
Actavis
Reckitt Benckier
Tyratech
Shionogi
TecLabs
Arborpharma
Major Pharmaceuticals
Logic Products
Tianren
ParaPRO

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Head Lice Infestation Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Head Lice Infestation Drug market by identifying its various subsegments.
Focuses on the key global Head Lice Infestation Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Head Lice Infestation Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Head Lice Infestation Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2019-2024 Global Head Lice Infestation Drug Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Head Lice Infestation Drug Consumption 2014-2024
2.1.2 Head Lice Infestation Drug Consumption CAGR by Region
2.2 Head Lice Infestation Drug Segment by Type
2.2.1 Lotion
2.2.2 Creams
2.2.3 Shampoo
2.2.4 Other
2.3 Head Lice Infestation Drug Consumption by Type
2.3.1 Global Head Lice Infestation Drug Consumption Market Share by Type (2014-2019)
2.3.2 Global Head Lice Infestation Drug Revenue and Market Share by Type (2014-2019)
2.3.3 Global Head Lice Infestation Drug Sale Price by Type (2014-2019)
2.4 Head Lice Infestation Drug Segment by Application
2.4.1 Children
2.4.2 Adult
2.5 Head Lice Infestation Drug Consumption by Application
2.5.1 Global Head Lice Infestation Drug Consumption Market Share by Application (2014-2019)
2.5.2 Global Head Lice Infestation Drug Value and Market Share by Application (2014-2019)
2.5.3 Global Head Lice Infestation Drug Sale Price by Application (2014-2019)

3 Global Head Lice Infestation Drug by Players
3.1 Global Head Lice Infestation Drug Sales Market Share by Players
3.1.1 Global Head Lice Infestation Drug Sales by Players (2017-2019)
3.1.2 Global Head Lice Infestation Drug Sales Market Share by Players (2017-2019)
3.2 Global Head Lice Infestation Drug Revenue Market Share by Players
3.2.1 Global Head Lice Infestation Drug Revenue by Players (2017-2019)
3.2.2 Global Head Lice Infestation Drug Revenue Market Share by Players (2017-2019)
3.3 Global Head Lice Infestation Drug Sale Price by Players
3.4 Global Head Lice Infestation Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Head Lice Infestation Drug Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Head Lice Infestation Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Head Lice Infestation Drug by Regions
4.1 Head Lice Infestation Drug by Regions
4.1.1 Global Head Lice Infestation Drug Consumption by Regions
4.1.2 Global Head Lice Infestation Drug Value by Regions
4.2 Americas Head Lice Infestation Drug Consumption Growth
4.3 APAC Head Lice Infestation Drug Consumption Growth
4.4 Europe Head Lice Infestation Drug Consumption Growth
4.5 Middle East & Africa Head Lice Infestation Drug Consumption Growth

5 Americas
5.1 Americas Head Lice Infestation Drug Consumption by Countries
5.1.1 Americas Head Lice Infestation Drug Consumption by Countries (2014-2019)
5.1.2 Americas Head Lice Infestation Drug Value by Countries (2014-2019)
5.2 Americas Head Lice Infestation Drug Consumption by Type
5.3 Americas Head Lice Infestation Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Head Lice Infestation Drug Consumption by Countries
6.1.1 APAC Head Lice Infestation Drug Consumption by Countries (2014-2019)
6.1.2 APAC Head Lice Infestation Drug Value by Countries (2014-2019)
6.2 APAC Head Lice Infestation Drug Consumption by Type
6.3 APAC Head Lice Infestation Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Head Lice Infestation Drug by Countries
7.1.1 Europe Head Lice Infestation Drug Consumption by Countries (2014-2019)
7.1.2 Europe Head Lice Infestation Drug Value by Countries (2014-2019)
7.2 Europe Head Lice Infestation Drug Consumption by Type
7.3 Europe Head Lice Infestation Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Head Lice Infestation Drug by Countries
8.1.1 Middle East & Africa Head Lice Infestation Drug Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Head Lice Infestation Drug Value by Countries (2014-2019)
8.2 Middle East & Africa Head Lice Infestation Drug Consumption by Type
8.3 Middle East & Africa Head Lice Infestation Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Head Lice Infestation Drug Distributors
10.3 Head Lice Infestation Drug Customer

11 Global Head Lice Infestation Drug Market Forecast
11.1 Global Head Lice Infestation Drug Consumption Forecast (2019-2024)
11.2 Global Head Lice Infestation Drug Forecast by Regions
11.2.1 Global Head Lice Infestation Drug Forecast by Regions (2019-2024)
11.2.2 Global Head Lice Infestation Drug Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Head Lice Infestation Drug Forecast by Type
11.8 Global Head Lice Infestation Drug Forecast by Application

12 Key Players Analysis
12.1 Bayer
12.1.1 Company Details
12.1.2 Head Lice Infestation Drug Product Offered
12.1.3 Bayer Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Bayer News
12.2 Omega Pharma
12.2.1 Company Details
12.2.2 Head Lice Infestation Drug Product Offered
12.2.3 Omega Pharma Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Omega Pharma News
12.3 Thornton and Ross
12.3.1 Company Details
12.3.2 Head Lice Infestation Drug Product Offered
12.3.3 Thornton and Ross Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Thornton and Ross News
12.4 Prestige Brands
12.4.1 Company Details
12.4.2 Head Lice Infestation Drug Product Offered
12.4.3 Prestige Brands Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Prestige Brands News
12.5 Perrigo
12.5.1 Company Details
12.5.2 Head Lice Infestation Drug Product Offered
12.5.3 Perrigo Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Perrigo News
12.6 Actavis
12.6.1 Company Details
12.6.2 Head Lice Infestation Drug Product Offered
12.6.3 Actavis Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Actavis News
12.7 Reckitt Benckier
12.7.1 Company Details
12.7.2 Head Lice Infestation Drug Product Offered
12.7.3 Reckitt Benckier Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Reckitt Benckier News
12.8 Tyratech
12.8.1 Company Details
12.8.2 Head Lice Infestation Drug Product Offered
12.8.3 Tyratech Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Tyratech News
12.9 Shionogi
12.9.1 Company Details
12.9.2 Head Lice Infestation Drug Product Offered
12.9.3 Shionogi Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Shionogi News
12.10 TecLabs
12.10.1 Company Details
12.10.2 Head Lice Infestation Drug Product Offered
12.10.3 TecLabs Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 TecLabs News
12.11 Arborpharma
12.12 Major Pharmaceuticals
12.13 Logic Products
12.14 Tianren
12.15 ParaPRO

13 Research Findings and Conclusion